Onegene Biotechnology
Latest round
- Series B
Last raised
- May 2022
Total raised
- $48M
Investors
- 20
About Onegene Biotechnology
Based in South Korea, and founded in 2016, Onegene Biotechnology provides therapeutics that help in the treatment of chronic diseases. As of 2023, the company is headed by its CEO Dr. Sungjin Park. The company offers multi-targeting tri-or tetra-specific protein-based drugs which are developed by using different therapeutic modalities and it is helpful in the treatment of non-alcoholic steatohepatitis (NASH), fibrotic diseases, and cancers. The firm protein-binding platform technology (UniStac) removes the heterodimerization engineering process and uses Enzyme-mediated protein-protein conjugation technology which helps in the treatment of complex and chronic diseases.
Who invested in Onegene Biotechnology
20 investors across 3 rounds
See all investors in Onegene Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Onegene Biotechnology
Who invested in Onegene Biotechnology?
Onegene Biotechnology has 20 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Onegene Biotechnology raised?
Onegene Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Onegene Biotechnology last raise money?
Onegene Biotechnology's most recent round on record is a Series B, in May 2022.
What does Onegene Biotechnology do?
Based in South Korea, and founded in 2016, Onegene Biotechnology provides therapeutics that help in the treatment of chronic diseases.
Where is Onegene Biotechnology headquartered?
Onegene Biotechnology is headquartered in South Korea.
Which VCs invest in companies like Onegene Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Onegene Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Onegene Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.